483 Kashiv BioSciences Mar 2019

483 Kashiv BioSciences Mar 2019

Rebecca Dombrowski FDA, Steven Fong FDA, Vaishali Patel FDA, Ramesh Potla FDA$119.00 - Available Now

FDA investigators audited the Kashiv BioSciences - Chicago, IL, United States facility and issued inspectional observations (via FDA 483) on 12 Mar 2019.

Product details

  • Category: Human Drugs
  • Inspection end: 12 Mar 2019
  • Location: Chicago, United States
  • FEI: 3011289655
Add To Cart